Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and ...

The Role of CRISPR Screens in Advancing Genomics CRISPR gene editing, enabled by the CRISPR/Cas9 system, has revolutionized ...

Researchers from more than 50 international institutions have launched Open Problems, a collaborative open-source platform to ...

Single-cell RNA-seq (scRNA-seq) has spent the past decade maturing into a foundational technology. Over that time, the ...

Researchers explore glioblastoma's genetic complexity using innovative spatial profiling, aiming to enhance treatment ...

Understanding how poultry responds to avian influenza at the cellular level could help geneticists create disease-resistant birds.

BioSkryb Genomics is a rapidly growing organization that is transforming single-cell molecular discovery and analysis. Through its single-cell whole genome and transcriptome amplification tools and ...

Researchers have developed a powerful new tool that makes it easier to study the mix of cell types in human tissue, which is crucial for understanding diseases such as cancer.

CS Genetics, a privately held genomics technology company, today announced the commercial launch of its 96-sample SimpleCell ...

DURHAM, N.C. & MÄNNEDORF, Switzerland--(BUSINESS WIRE)-- BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb ...

BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb's 384-well format of the ResolveOME(TM) Whole Genome and ...

BioSkryb Genomics and Tecan Group (SIX Swiss Exchange: TECN), today introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ Whole Genome and ...